Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine May/22/2021 48 0
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine May/22/2021 12 1
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 40 46
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Apr/23/2021 13 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Remdesivir Approved by FDA Experimental Antiviral Apr/21/2021 61 5
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Apr/16/2021 24 7